New anticoagulants--the path from discovery to clinical practice.
Publication
, Journal Article
Lohrmann, J; Becker, RC
Published in: The New England journal of medicine
June 2008
Duke Scholars
Published In
The New England journal of medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
June 2008
Volume
358
Issue
26
Start / End Page
2827 / 2829
Related Subject Headings
- Venous Thrombosis
- Venous Thromboembolism
- Thiophenes
- Rivaroxaban
- Morpholines
- Humans
- General & Internal Medicine
- Factor Xa Inhibitors
- Enoxaparin
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Lohrmann, J., & Becker, R. C. (2008). New anticoagulants--the path from discovery to clinical practice. The New England Journal of Medicine, 358(26), 2827–2829. https://doi.org/10.1056/nejme0804291
Lohrmann, Jens, and Richard C. Becker. “New anticoagulants--the path from discovery to clinical practice.” The New England Journal of Medicine 358, no. 26 (June 2008): 2827–29. https://doi.org/10.1056/nejme0804291.
Lohrmann J, Becker RC. New anticoagulants--the path from discovery to clinical practice. The New England journal of medicine. 2008 Jun;358(26):2827–9.
Lohrmann, Jens, and Richard C. Becker. “New anticoagulants--the path from discovery to clinical practice.” The New England Journal of Medicine, vol. 358, no. 26, June 2008, pp. 2827–29. Epmc, doi:10.1056/nejme0804291.
Lohrmann J, Becker RC. New anticoagulants--the path from discovery to clinical practice. The New England journal of medicine. 2008 Jun;358(26):2827–2829.
Published In
The New England journal of medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
June 2008
Volume
358
Issue
26
Start / End Page
2827 / 2829
Related Subject Headings
- Venous Thrombosis
- Venous Thromboembolism
- Thiophenes
- Rivaroxaban
- Morpholines
- Humans
- General & Internal Medicine
- Factor Xa Inhibitors
- Enoxaparin
- Anticoagulants